Ethiopian Pharmaceuticals Supply AG Pharmaceutical Import Profile — Djibouti (DGFT 2022–2026)

Name: Ethiopian Pharmaceuticals Supply AG Pharmaceutical Import Records from India — 7 Products, $4.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ethiopian Pharmaceuticals Supply AG — Pharmaceutical Importer Profile (2026) | 7 Products, $4.7M Trade | TransData Nexus

Ethiopian Pharmaceuticals Supply AG

Pharmaceutical Importer · Djibouti · Nutritional Supplements Focus · $4.7M Total Trade · DGFT Verified

Ethiopian Pharmaceuticals Supply AG is a pharmaceutical importer based in Djibouti with a total trade value of $4.7M across 7 products in 5 therapeutic categories. Based on 97 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ethiopian Pharmaceuticals Supply AG sources from 20 verified Indian suppliers, with Fresenius Kabi India Private Limited accounting for 39.2% of imports.

Ethiopian Pharmaceuticals Supply AG — Import Portfolio & Supplier Network

Ethiopian Pharmaceuticals Supply AG import network — 7 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ethiopian Pharmaceuticals Supply AG?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Fresenius Kabi India Private Limited	$3.8M	83	39.2%
Macleods Pharmaceuticals Limited	$1.6M	53	16.5%
Zim Laboratories Limited	$1.2M

What Formulations Does Ethiopian Pharmaceuticals Supply AG Import?

Formulation	Value	Ships
Human medicines-sodium chloride	$3.7M	81
Doxyzim 100 (doxycycline capsules BP	$634.6K	13
Drugs and pharmaceuticals harmless	$321.9K	8
Harmless medicines: artemeter 20MG and	$311.2K	7
Iron folate[ferrous sulfate	$300.0K	6
Harmless medicines: lumerax dt 20/120MG	$200.0K	4
Peptica gel alumina, magnesia and simethicone oral suspension u.s.p.	$200.0K	4
Drugs and pharmaceuticals harmless medicines lamivudine 300 MG and tenofovir disoproxil fumarate 300 MG	$150.0K	3
Sofosbuvir 400MG + daclatasvir 60MG tablets 28's - myhep dvir 19749 packs x 28	$150.0K	3
Sofosbuvir 400MG + daclatasvir 60MG tablets 28's - myhep dvir 19749 packs x 28 nos.	$150.0K	3
Iron folate[ferrous sulfate 200 MG+folic acid 0.40 MG tablets] 10x10 eh film coated tablet cont. dried ferrous sulfate	$150.0K	3
Drugs and pharmaceuticals harmless medicines phenytoin tablets BP 100	$150.0K	3
Aldaz (albendazole chewable tablets	$135.4K	3
Mgl iv 100 ML eth	$127.4K	6
Nicardia retard 20MG 10x10tabs eth	$100.0K	2

Ethiopian Pharmaceuticals Supply AG imports 75 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 7 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sodium	Nutritional Supplements	$3.0M	61	0.8%	19
2	Doxycycline	Antibiotics	$650.0K	13	0.5%	11
3	Folic	Nutritional Supplements	$450.0K	9	0.8%	3
4	Ceftriaxone	Advanced Antibiotics	$350.0K	7	0.1%	15
5	Clarithromycin	Antibiotics	$150.0K	3	0.2%	17
6	Ifosfamide	Advanced Oncology	$31.9K	2	1.3%	13
7	Vinblastine	Oncology	$14.1K	2	1.9%	6

Ethiopian Pharmaceuticals Supply AG imports 7 pharmaceutical products across 5 categories into Djibouti totaling $4.7M.

Ethiopian Pharmaceuticals Supply AG — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Ethiopian Pharmaceuticals Supply AG is a pharmaceutical importer based in Djibouti, specializing in the procurement of finished pharmaceutical formulations from India. The company plays a pivotal role in Djibouti's pharmaceutical distribution network, ensuring the availability of essential medications across the nation. While specific details about its parent company are not publicly disclosed, Ethiopian Pharmaceuticals Supply AG's operations are integral to the healthcare supply chain in Djibouti.

2Distribution Network

The company maintains a centralized warehouse in Djibouti, strategically located to facilitate efficient distribution throughout the country. Its logistics capabilities include a fleet of temperature-controlled vehicles, ensuring the safe and timely delivery of pharmaceutical products. Ethiopian Pharmaceuticals Supply AG's geographic coverage extends beyond Djibouti, serving neighboring regions and contributing to the broader East African pharmaceutical supply chain.

3Industry Role

Ethiopian Pharmaceuticals Supply AG functions primarily as a wholesaler and distributor within Djibouti's pharmaceutical supply chain. By importing a diverse range of finished pharmaceutical formulations from India, the company ensures a steady supply of essential medications to local pharmacies, hospitals, and clinics. Its role is crucial in bridging the gap between international pharmaceutical manufacturers and the domestic healthcare providers in Djibouti.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ethiopian Pharmaceuticals Supply AG

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 99% of the total import value. This concentration indicates a strategic focus on high-demand medications, ensuring consistent supply and potentially leveraging bulk purchasing advantages. However, such dependency on a limited product range may pose risks if market dynamics shift or if there are disruptions in the supply chain. The stability of the company's relationships with its Indian suppliers, particularly the top suppliers like FRESENIUS KABI INDIA PRIVATE LIMITED and MACLEODS PHARMACEUTICALS LIMITED, is vital to mitigate these risks.

2Supply Chain Resilience

Ethiopian Pharmaceuticals Supply AG's supply chain resilience is bolstered by its partnerships with multiple Indian suppliers, reducing the risk associated with single-source dependency. The diversity in formulations imported, spanning seven products across five therapeutic categories, further enhances supply chain robustness. While the company primarily relies on sea routes for transportation, it maintains contingency plans with alternative shipping routes and air freight options to address potential disruptions. Ensuring that all imported products comply with international regulatory standards, such as those set by the World Health Organization (WHO), is a priority to maintain product quality and safety.

Importing Pharmaceuticals into Djibouti — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Djibouti

1Regulatory Authority & Framework

Djibouti's pharmaceutical imports are regulated by the Ministry of Health, which oversees the approval and monitoring of imported medications. Key legislation governing pharmaceutical imports includes the Pharmaceutical Law, which sets standards for drug quality, safety, and efficacy. The marketing authorization pathway for Indian generics involves submitting detailed dossiers to the Ministry of Health, demonstrating compliance with Djibouti's regulatory requirements. This process ensures that imported generics meet the necessary standards before entering the market.

2Import Licensing & GMP

Importers in Djibouti must obtain valid licenses from the Ministry of Health and the Ministry of Trade Development to legally import pharmaceutical products. These licenses are contingent upon compliance with Good Manufacturing Practice (GMP) standards, which are recognized internationally, including EU GMP, WHO GMP, and PIC/S certifications. Wholesale distribution authorization is granted upon meeting these regulatory requirements, ensuring that imported pharmaceuticals are safe and effective for public use.

3Quality & Labeling

Ethiopian Pharmaceuticals Supply AG — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Ethiopian Pharmaceuticals Supply AG's focus on nutritional supplements, antibiotics, and advanced antibiotics aligns with the prevalent health concerns in Djibouti, such as malnutrition and infectious diseases. The market demand for these products is driven by the need to address nutritional deficiencies and combat bacterial infections. By prioritizing these therapeutic areas, the company effectively meets the healthcare needs of the population.

2Sourcing Profile

The company's sourcing strategy emphasizes generic drugs, particularly those with established efficacy and safety profiles. Formulation preferences include oral dosage forms like tablets and capsules, as well as injectable forms for hospital settings. India's robust pharmaceutical manufacturing sector, known for its compliance with international standards, makes it a preferred sourcing destination for Ethiopian Pharmaceuticals Supply AG.

3Market Positioning

Based on its product mix, Ethiopian Pharmaceuticals Supply AG serves a broad segment of the Djibouti market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. Its comprehensive portfolio ensures that various healthcare providers have access to essential medications, thereby supporting the overall healthcare infrastructure in Djibouti.

Seller's Guide — How to Become a Supplier to Ethiopian Pharmaceuticals Supply AG

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Djibouti market by offering products that complement Ethiopian Pharmaceuticals Supply AG's existing portfolio, such as specialized formulations or innovative drug delivery systems. Gaps in the current sourcing include a limited range of therapeutic areas and dosage forms. Addressing these gaps could enhance the company's competitiveness and meet the evolving healthcare needs of Djibouti.

2Requirements & Qualifications

Indian exporters seeking to supply Ethiopian Pharmaceuticals Supply AG and the Djibouti market must ensure that their products comply with international GMP standards recognized by Djibouti's regulatory authorities. Additionally, products must meet labeling requirements in French and adhere to serialization mandates. Obtaining the necessary import licenses and wholesale distribution authorizations is essential for market entry.

3How to Approach

Frequently Asked Questions — Ethiopian Pharmaceuticals Supply AG

What products does Ethiopian Pharmaceuticals Supply AG import from India?

Ethiopian Pharmaceuticals Supply AG imports 7 pharmaceutical products across 5 categories. Top imports: Sodium ($3.0M), Doxycycline ($650.0K), Folic ($450.0K), Ceftriaxone ($350.0K), Clarithromycin ($150.0K).

Who supplies pharmaceuticals to Ethiopian Pharmaceuticals Supply AG from India?

Ethiopian Pharmaceuticals Supply AG sources from 20 verified Indian suppliers. The primary supplier is Fresenius Kabi India Private Limited (39.2% of imports, $3.8M).

What is Ethiopian Pharmaceuticals Supply AG's total pharmaceutical import value?

Ethiopian Pharmaceuticals Supply AG's total pharmaceutical import value from India is $4.7M, based on 97 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ethiopian Pharmaceuticals Supply AG focus on?

Ethiopian Pharmaceuticals Supply AG imports across 5 categories. The largest: Nutritional Supplements (74.5%), Antibiotics (17.0%), Advanced Antibiotics (7.5%).

Get Full Ethiopian Pharmaceuticals Supply AG Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.